Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hantao Ye Formula Granule is a Traditional Chinese Medicine (TCM) product developed by Guizhou Yibai Pharmaceutical. It is a standardized, soluble, single-herb extract derived from the leaves of *Pterocarya stenoptera* (Chinese wingnut). In TCM, Hantao Ye is traditionally utilized for its anti-inflammatory and analgesic properties, often applied in the treatment of conditions involving pain and inflammation. Guizhou Yibai Pharmaceutical was designated as a pilot enterprise for TCM formula granule research in Guizhou Province in 2020, leading to the development and standardization of this product. While provincial standards for the granule have been established or are pending, specific clinical development phases and molecular targets remain undisclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hantao Ye Formula Granule.